At this point, is more widespread testing of all patients with unexplained pneumonia (even those who haven’t been to China) warranted from a societal cost-effectiveness perspective? It’s a question that needs to be asked.
Testing For COVID-19 In All Patients With Unexplained Pneumonia Is Probably Not Cost-Effective
